BNP Paribas Arbitrage SA Has $9.73 Million Holdings in Waters Corporation (WAT)

BNP Paribas Arbitrage SA raised its stake in Waters Corporation (NYSE:WAT) by 46.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 54,218 shares of the medical instruments supplier’s stock after buying an additional 17,280 shares during the quarter. BNP Paribas Arbitrage SA owned approximately 0.07% of Waters Corporation worth $9,733,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the business. Janus Henderson Group PLC grew its holdings in shares of Waters Corporation by 20,670.6% during the 2nd quarter. Janus Henderson Group PLC now owns 1,929,793 shares of the medical instruments supplier’s stock worth $354,773,000 after purchasing an additional 1,920,502 shares during the period. Koch Industries Inc. grew its holdings in shares of Waters Corporation by 36,932.0% during the 2nd quarter. Koch Industries Inc. now owns 534,742 shares of the medical instruments supplier’s stock worth $532,000 after purchasing an additional 533,298 shares during the period. Fundsmith LLP grew its holdings in shares of Waters Corporation by 11.7% during the 2nd quarter. Fundsmith LLP now owns 3,833,955 shares of the medical instruments supplier’s stock worth $704,834,000 after purchasing an additional 401,420 shares during the period. Renaissance Technologies LLC grew its holdings in shares of Waters Corporation by 214.5% during the 2nd quarter. Renaissance Technologies LLC now owns 526,400 shares of the medical instruments supplier’s stock worth $96,773,000 after purchasing an additional 359,000 shares during the period. Finally, American Century Companies Inc. grew its holdings in shares of Waters Corporation by 200.4% during the 3rd quarter. American Century Companies Inc. now owns 512,899 shares of the medical instruments supplier’s stock worth $92,076,000 after purchasing an additional 342,134 shares during the period. Institutional investors own 91.82% of the company’s stock.

In other Waters Corporation news, SVP Rohit Khanna sold 26,913 shares of the stock in a transaction dated Friday, October 27th. The stock was sold at an average price of $197.93, for a total value of $5,326,890.09. Following the sale, the senior vice president now owns 13,677 shares of the company’s stock, valued at approximately $2,707,088.61. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Elizabeth B. Rae sold 12,000 shares of the stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $197.95, for a total value of $2,375,400.00. Following the completion of the sale, the senior vice president now directly owns 18,129 shares in the company, valued at approximately $3,588,635.55. The disclosure for this sale can be found here. Insiders sold a total of 57,313 shares of company stock worth $11,120,642 in the last ninety days. 5.07% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: This news story was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://ledgergazette.com/2017/11/16/bnp-paribas-arbitrage-sa-has-9-73-million-holdings-in-waters-corporation-wat.html.

Waters Corporation (NYSE WAT) opened at $194.84 on Thursday. Waters Corporation has a 12 month low of $133.35 and a 12 month high of $199.78. The company has a current ratio of 6.16, a quick ratio of 5.71 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $15,559.84, a PE ratio of 27.17, a P/E/G ratio of 2.84 and a beta of 0.83.

Waters Corporation (NYSE:WAT) last posted its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.03. The company had revenue of $565.58 million for the quarter, compared to analyst estimates of $555.25 million. Waters Corporation had a return on equity of 23.61% and a net margin of 24.34%. Waters Corporation’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.57 EPS. analysts forecast that Waters Corporation will post 7.42 earnings per share for the current year.

A number of research firms have recently weighed in on WAT. Goldman Sachs Group, Inc. (The) began coverage on Waters Corporation in a report on Tuesday, September 26th. They set a “hold” rating and a $180.00 price target for the company. BidaskClub upgraded Waters Corporation from a “buy” rating to a “strong-buy” rating in a report on Wednesday, August 16th. Jefferies Group LLC reiterated a “hold” rating and set a $175.00 price target on shares of Waters Corporation in a report on Thursday, July 27th. Morgan Stanley reiterated an “underweight” rating and set a $183.00 price target (up from $174.00) on shares of Waters Corporation in a report on Wednesday, July 26th. Finally, Zacks Investment Research upgraded Waters Corporation from a “hold” rating to a “buy” rating and set a $211.00 price target for the company in a report on Monday, October 23rd. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $193.62.

Waters Corporation Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT).

Institutional Ownership by Quarter for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply